Title: PrEP today. Data discussions on an HIV-1 PrEP option

Date/Time: Monday, July 21 | 11:30am-12:30pm

Location: Presentation Theater #1

Description: During this educational session, attendees will learn about an alternative PrEP option to help prevent HIV in their patients. The program will review important information, clinical data, and dosing and administration, and provide guidance on identifying patients who would benefit. In addition, the program will also feature a Patient Ambassador who will share their personal experience with this PrEP option and discuss how it impacted their life.

Sponsored by: ViiV Healthcare

Title: From LDL-C to Lp(a): Opportunities to Reduce the Rising Tide of Cardiovascular Events

Date/Time: Monday, July 21 | 11:30am-12:30pm

Location: Presentation Theater #2

Description: Cardiovascular disease (CVD) is still the leading cause of death in the United States and the trend is moving in the wrong direction, with 2022 setting a record for deaths due to CVD in the US at close to 1 million. LDL-cholesterol is a major modifiable cardiovascular risk factor, which continues to be poorly controlled and elevated Lp(a) is a powerful, causal, independent genetic risk factor for CVD which is prevalent in approximately 20% of the population.

The Family Heart Foundation is a non-profit organization dedicated to research, education, and advocacy and as part of our ongoing research efforts, we have examined the state of LDL-C control among 38M Americans at high and very high-risk for cardiovascular disease in the proprietary Family Heart Database. This session will provide an update on current guidelines related to LDL-C management and Lp(a) screening and focus on key findings and insights from an analysis of the Family Heart database.

Sponsored by: Family Heart Foundation

Title: Addressing Vaccine-Preventable Diseases in Adults at Risk: Case Examples Among Vulnerable Patients

Date/Time: Monday, July 21 | 1:00-2:00 PM

Location: Presentation Theater #1

Description: Learn about challenges in addressing vaccine-preventable diseases (VPDs) in vulnerable US adults. Our presenter will highlight differences in VPD burden, risk factors, and vaccine uptake, focusing on respiratory syncytial virus and herpes zoster, and review CDC adult vaccination recommendations.

Sponsored by: GSK

Title: Understanding ATTR-CM: A Distinct and Treatable Cause of Heart Failure. 

Date/Time: Monday, July 21 | 1:00-2:00 PM

Location: Presentation Theater #2

Description: Presentation on understanding ATTR-CM (Cardiac Amyloidosis), a distinct and treatable cause of heart failure.  

Sponsored by: BridgeBio

Title: Optimizing Social Needs Screening: Workforce Insights from an Integrated Healthcare System

Date/Time: Monday, July 21 | 3:00-4:00 PM

Location: Presentation Theater #2

Description: Sutter Health began screening for Social Drivers of Health in acute care settings in November 2023. Surveys from January-July 2024 hospitalizations showed staff understood SDOH’s importance but revealed training and workflow confidence gaps. Enhanced education and role support were recommended for quality improvement.

Sponsored by: Sutter Health

Title: APOL1-Mediated Kidney Disease (AMKD): Beneath the Surface of Kidney Disease in People of African Ancestry

Date/Time: Tuesday, July 22 | 11:30 AM-12:30 PM

Location: Presentation Theater #1

Description: Discovery of the APOL1 gene variants has revolutionized understanding of excess kidney failure experienced by African Americans. Until recently, AMKD has been hidden in plain sight, from nephrotic syndrome to “hypertensive” kidney disease to preeclampsia. The rapidly evolving scientific landscape heralds a promising new era.

Sponsored by: Vertex Pharmaceuticals

Title: Learn about a nonhormonal FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause

Date/Time: Tuesday, July 22 | 11:30 AM – 12:30 PM

Location: Presentation Theater #2

Description: In this session, we will review an FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause, including indication, mechanism of action, and clinical safety and efficacy.

Sponsored by: Astellas

Title: High HopeS:​ Overcoming Barriers and Advancing Care for Patients ​With Hidradenitis Suppurativa

Date/Time: Tuesday, July 22 | 1:00-2:00 PM

Location: Presentation Theater #1

Description: Understand and learn about HS and the barriers faced by those who manage and live it on a day to day basis. The audience will leave with an appreciation of the barriers faced by patients, healthcare providers, and administrators, while trying to improve and advance patient care.

Sponsored by: UCB, Inc.

Title: Shifting to Inhaled Corticosteroid-Containing Asthma Rescue

Date/Time: Tuesday, July 22 | 1:00-2:00 PM

Location: Presentation Theater #2

Description: How do YOU approach rescue therapy for your patients with asthma? Join us as we examine the role of variable inflammation in the occurrence of asthma exacerbations and the consequent burden of systemic corticosteroid exposures. See recent recommendations from GINA and NAEPP and hear about data on a rescue therapy option that may broaden your perspective.

Sponsored by: AstraZeneca

Title: USPI YEZTUGO

Date/Time: Tuesday, July 22 | 3:00-4:00 PM

Location: Presentation Theater #1

Description:

Objectives

• Indications and Usage
• Dosage and Administration
• Contraindications
• Warnings and Precautions
• Adverse Reactions
• Drug Interactions
• Use in Specific Populations
• Clinical Studies

Sponsored by: Gilead Health Sciences – HIV